Publicaciones en colaboración con investigadores/as de Universidad de Castilla-La Mancha (20)

2022

  1. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis

    Therapeutic Advances in Medical Oncology, Vol. 14

2021

  1. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. Click Synthesis of Size-and Shape-Tunable Star Polymers with Functional Macrocyclic Cores for Synergistic DNA Complexation and Delivery

    Biomacromolecules, Vol. 21, Núm. 12, pp. 5173-5188

  2. Crocetin isolated from the natural food colorant saffron reduces intracellular fat in 3T3-L1 adipocytes

    Foods, Vol. 9, Núm. 11

  3. Modificaciones farmacocinéticas y farmacodinámicas en el anciano

    Tratado de medicina geriátrica: fundamentos de la atención sanitaria a los mayores (Elsevier), pp. 72-82

2019

  1. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer

    Nanomaterials, Vol. 9, Núm. 12

2015

  1. Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 70, Núm. 6, pp. 675-685

2013

  1. Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 705-717

2012

  1. Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain

    Journal of Neuroscience Research, Vol. 90, Núm. 2, pp. 518-528

  2. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model

    Neurobiology of Aging, Vol. 33, Núm. 3, pp. 625.e11-625.e20

2011

  1. A proteomic analysis of PKCε targets in astrocytes: Implications for astrogliosis

    Amino Acids, Vol. 40, Núm. 2, pp. 641-651

2010

  1. Delayed pre-conditioning by 3-nitropropionic acid prevents 3,4-methylenedioxymetamphetamine-induced 5-HT deficits

    Journal of Neurochemistry, Vol. 114, Núm. 3, pp. 843-852

  2. Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1802, Núm. 11, pp. 1036-1047

  3. Methylenedioxymethamphetamine inhibits mitochondrial complex i activity in mice: A possible mechanism underlying neurotoxicity

    British Journal of Pharmacology, Vol. 160, Núm. 2, pp. 233-245

  4. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF

    Neurobiology of Disease, Vol. 38, Núm. 2, pp. 237-245

2009

  1. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine- induced 5-HT deficits in the rat

    Journal of Neurochemistry, Vol. 108, Núm. 3, pp. 755-766

2008

  1. Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: Role of mitochondrial ATP-sensitive potassium channels, Akt and ERK

    Journal of Neurochemistry, Vol. 104, Núm. 4, pp. 914-925

2007

  1. ER-stress apoptotic signalling in ischemic astrocytes depends on Caspase-11 activation

    NEURON GLIA BIOLOGY

  2. Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: Modulation of cytotoxicity by nitric oxide

    Molecular Pharmacology, Vol. 72, Núm. 2, pp. 407-417